Cargando…
Engineered Fc-glycosylation switch to eliminate antibody effector function
Antibodies mediate effector functions through Fcγ receptor (FcγR) interactions and complement activation, causing cytokine release, degranulation, phagocytosis, and cell death. They are often undesired for development of therapeutic antibodies where only antigen binding or neutralization would be id...
Autores principales: | Zhou, Qun, Jaworski, Julie, Zhou, Yanfeng, Valente, Delphine, Cotton, Joanne, Honey, Denise, Boudanova, Ekaterina, Beninga, Jochen, Rao, Ercole, Wei, Ronnie, Mauriac, Christine, Pan, Clark, Park, Anna, Qiu, Huawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531572/ https://www.ncbi.nlm.nih.gov/pubmed/32892677 http://dx.doi.org/10.1080/19420862.2020.1814583 |
Ejemplares similares
-
Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life
por: Mackness, Brian C., et al.
Publicado: (2019) -
Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models
por: Valente, Delphine, et al.
Publicado: (2020) -
Engineering an anti-CD52 antibody for enhanced deamidation stability
por: Qiu, Huawei, et al.
Publicado: (2019) -
Site-Specific Antibody Conjugation to Engineered Double Cysteine Residues
por: Zhou, Qun, et al.
Publicado: (2021) -
Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G
por: Einarsdottir, Helga K., et al.
Publicado: (2012)